Big Pharma delivers another life-saving medical advance, and another demonstration of the folly of price controls.

Elton John and Jeanine White, the mother of Ryan White, urge Congress not to cut funding for lifesaving HIV and AIDS programs ...

Utah biochemist Wesley Sundquist has achieved yet another milestone with the Food and Drug Administration approval of an antiviral drug for HIV prevention based on his findings.

Researchers at Massachusetts Institute of Technology (MIT) have developed a way to 'supercharge' vaccines to the extent that ...

The Food and Drug Administration approved the preventative use of lenacapavir, made by Gilead Sciences, on Wednesday. Experts ...

Yeztugo, approved by the FDA, was highly effective in two randomized trials. It costs $28,218 per year, and people have to be HIV-negative to get it.

University of Michigan researchers have uncovered new details of the process that HIV uses to hijack cells' transportation ...

HIV infections surged 500 percent in first quarter 2025. Fifty-seven cases were recorded each day, averaging 1,700 cases a month, in age group 15-25. Youngest victim is a 12-year-old in Palawan.

Gilead's CEO says he's committed to making sure people around the world can get his firm's new HIV prevention shot Yeztugo.

HIV and AIDS information and facts. Read latest medical articles and view educational videos on AIDS and HIV symptoms and treatments. Stay informed about new developments on the AIDS/HIV front.

LA CAB plus RPV effectively maintained virologic suppression among patients with infection in real-world clinical practice.

Gilead has partnered with six generic manufacturers to expand access to HIV Drug lenacapavir in high-incidence, resource-limited countries following promising clinical trial results.